adMare BioInnovations

Twenty-two leaders from across Canada's life sciences sector join adMare's flagship leadership development program to strengthen the leadership pipeline driving company creation and growth. Vancouver (BC), Toronto (ON), and Montreal (QC) - September 24, 2

Co-authored by Matthew Carlyle, President and CEO, adMare BioInnovations; Maura Campbell, President and CEO, OBIO; Jason Field, President and CEO, Life Sciences Ontario; Benoît Larose, President and CEO, BIOQuébec; Wendy Hurlburt, President and CEO, Life

Originally published: https://thefutureeconomy.ca/op-eds/the-future-of-bioinnovation-what-canada-must-do-now-to-lead/ Canada is making a series of deliberate choices about its economic and strategic future. We are diversifying trading partners, investing

Canada's life sciences company creation engine invites experienced leaders and emerging C-suite executives to apply for its flagship leadership development program Vancouver (BC), Toronto (ON), and Montreal (QC) - June 16, 2026 - adMare BioInnovations, Ca

VoxCell BioInnovation, adMare BioInnovations partner to advance novel antibody therapies in a human-relevant vascularized tissue platform

Collaboration applies perfusable, immune-competent 3D bioprinted cancer tissue models to preclinical evaluation of next-generation oncology biologics, supporting the FDA's push toward more predictive, human-relevant testing and reduced reliance on animal

National competition, in collaboration with adMare BioInnovations, demonstrates AbbVie

MONTREAL, April 30, 2026 - AbbVie (NYSE: ABBV), jointly with adMare BioInnovations, today recognized RIME Therapeutics as the recipient of the AbbVie Biotech Innovators Award, a prize designed to help foster innovation and support growth in Quebec's life

CAMBRIDGE, UK and MONTREAL, CANADA, 23 April 2026 - Epitopea, a transatlantic biotech developing off-the-shelf, durable, RNA-based cancer immunotherapies, today announced that it has received approval from the UK's Medicines and Healthcare products Regula